|
Argos Therapeutics Presents Positive Phase 2 Data Of Its Arcelis™ Personalized Immunotherapy Platform In Metastatic RCC At ASCO GU Symposium
Argos Therapeutics announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium...
Date: Tue, 09 Mar 2010 22:00:00 PST
UK's First Pooled Kidney Transplants
The first pooled kidney transplants involving three donor-recipient couples where each recipient received a kidney from a donor they did not know, has successfully taken place in the UK. The transplants took place at the end of 2009 and involved three hospitals, Hammersmith and Guy's and St Thomas' in London, and the Royal Infirmary in Edinburgh...
Date: Tue, 09 Mar 2010 03:00:00 PST
PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented At Leading Medical Meeting Confirm
Gen-Probe's (Nasdaq: GPRO) PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco...
Date: Tue, 09 Mar 2010 01:00:00 PST
Prostate Cancer Therapy Correlates To Specialist Seen
New research published in today's issue of the Archives of Internal Medicine (Vol. 170, No. 5), by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues at Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive...
Date: Tue, 09 Mar 2010 01:00:00 PST
Occupational Sunlight Exposure And Kidney Cancer Risk In Men
According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women...
Date: Mon, 08 Mar 2010 04:00:00 PST
U.S. Representative John B. Larson Visits Connecticut Surgical Group - American Urological Association
U.S. Representative John B. Larson (D-CT) visited the Glastonbury office of Connecticut Surgical Group, a group surgical practice with 14 locations in the greater Hartford area, on Friday, February 26. Urologist Arthur Tarantino, MD, led Rep. Larson on a tour of the facility and explained to the Congressman how the practice serves as a specialty care resource for the community. Dr...
Date: Sun, 07 Mar 2010 01:00:00 PST
Copyright 2010 Medical News Today
|
